Photocatalytic microrobots for treating bacterial infections deep within sinuses

Haidong Yu1,2, Xurui Liu3, Yabin Zhang1

  • 1School of Chemistry and Chemical Engineering, State Key Laboratory of Featured Metal Materials and Life-cycle Safety for Composite Structures, School of Resources, Environment and Materials, Guangxi University, Nanning 530004, P. R. China.

Science Robotics
|June 25, 2025
PubMed

Insights

This study introduces novel photocatalytic microrobots (CBMRs) that effectively treat deep-body bacterial infections. The microrobots reduce pus viscosity and disrupt biofilms, offering a promising minimally invasive therapeutic approach.

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Nanotechnology

Background:

  • Microrobotic treatments face challenges from viscous pus and limited antibacterial payload integration.
  • Targeted therapy for deep-seated biofilm infections requires overcoming biological barriers.

Purpose of the Study:

  • To develop a magnetically guided, optical fiber-assisted microrobotic platform for treating bacterial infections in deep mucosal cavities.
  • To address limitations of conventional treatments by enhancing microrobot penetration and antibacterial efficacy.

Main Methods:

  • Fabrication of copper (Cu) single atom-doped bismuth oxoiodide (BiOI) microrobots (CBMRs).
  • Magnetic guidance and real-time X-ray tracking of CBMRs using an optical fiber-assisted platform.
  • Evaluation of photothermal effect on pus viscosity and reactive oxygen species (ROS) generation for biofilm disruption.

Main Results:

  • CBMRs demonstrated enhanced penetration capability (over threefold increase) due to photothermal viscosity reduction.
  • Visible-light irradiation induced robust ROS generation, leading to efficient biofilm disruption and reduced bacterial viability.
  • Successful in vivo validation in a rabbit sinusitis model.

Conclusions:

  • The developed optical fiber-assisted microrobotic platform shows significant potential for treating deep-seated bacterial infections.
  • CBMRs offer a novel strategy for overcoming biological barriers and delivering targeted antimicrobial therapy.
  • This integrated approach represents a promising advancement for clinically relevant infection management.